PTC Therapeutics Inc. buy UBS Group AG
Start price
29.07.25
/
50%
€43.60
Target price
29.07.26
€68.98
Performance (%)
47.94%
Price
12.12.25
€63.00
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for PTC Therapeutics Inc. has seen massive gains of 47.94%. This prediction currently runs until 29.07.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | -3.817% | -3.817% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by UBS_Group_AG for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at UBS Group AG from $71.00 to $80.00. They now have a "buy" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by UBS_Group_AG for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.60
03.12.24
03.12.24
€67.48
03.12.25
03.12.25
28.02%
04.12.25
04.12.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€31.00
26.08.24
26.08.24
€42.11
26.08.25
26.08.25
34.19%
27.08.25
27.08.25